BIOMARIN PHARMACEUTICAL INC Insider Trading for May 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for May 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 5,120 | 0 | 23,970 | 18.9 K to 24 K (+27.16 %) |
| May 27 2021 | BMRN | BIOMARIN PHARMACEU ... | HOMBACH ROBERT J. | Director | Grant | A | 0.00 | 5,120 | 0 | 21,330 | 16.2 K to 21.3 K (+31.59 %) |
| May 27 2021 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 5,120 | 0 | 72,088 | 67 K to 72.1 K (+7.65 %) |
| May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,513 | 225,509 | 0 | |
| May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.29 | 8,513 | 657,970 | 303,839 | 312.4 K to 303.8 K (-2.73 %) |
| May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,513 | 225,509 | 312,352 | 303.8 K to 312.4 K (+2.80 %) |
| May 11 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Option Exercise | M | 28.23 | 6,709 | 189,395 | 0 | |
| May 11 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Sell | S | 79.50 | 6,709 | 533,366 | 31,357 | 38.1 K to 31.4 K (-17.62 %) |
| May 11 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Buy | M | 28.23 | 6,709 | 189,395 | 38,066 | 31.4 K to 38.1 K (+21.40 %) |
| May 11 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Grant | A | 62.41 | 341 | 21,281 | 31,357 | 31 K to 31.4 K (+1.10 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 25,000 | 662,250 | 8,513 | |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 25,000 | 662,250 | 33,513 | |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.39 | 3,329 | 264,303 | 303,839 | 307.2 K to 303.8 K (-1.08 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.77 | 6,115 | 481,672 | 307,168 | 313.3 K to 307.2 K (-1.95 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.60 | 15,556 | 1,207,146 | 313,283 | 328.8 K to 313.3 K (-4.73 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 25,000 | 662,250 | 328,839 | 303.8 K to 328.8 K (+8.23 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.69 | 10,175 | 800,671 | 303,839 | 314 K to 303.8 K (-3.24 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.01 | 14,825 | 1,156,528 | 314,014 | 328.8 K to 314 K (-4.51 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 25,000 | 662,250 | 328,839 | 303.8 K to 328.8 K (+8.23 %) |
| May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 62.41 | 341 | 21,281 | 303,839 | 303.5 K to 303.8 K (+0.11 %) |
| May 07 2021 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 26.49 | 15,000 | 397,350 | 0 | |
| May 07 2021 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Sell | S | 78.38 | 5,068 | 397,245 | 94,272 | 99.3 K to 94.3 K (-5.10 %) |
| May 07 2021 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 26.49 | 15,000 | 397,350 | 99,340 | 84.3 K to 99.3 K (+17.79 %) |
| May 05 2021 | BMRN | BIOMARIN PHARMACEU ... | Guyer Charles Greg | EVP, Chief Technica ... | Payment of Exercise | F | 78.35 | 3,986 | 312,303 | 41,695 | 45.7 K to 41.7 K (-8.73 %) |
| May 05 2021 | BMRN | BIOMARIN PHARMACEU ... | Guyer Charles Greg | EVP, Chief Technica ... | Grant | A | 62.41 | 221 | 13,792 | 45,681 | 45.5 K to 45.7 K (+0.49 %) |
| May 04 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 78.30 | 2,089 | 163,569 | 64,108 | 66.2 K to 64.1 K (-3.16 %) |
| May 04 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 78.30 | 2,584 | 202,327 | 66,197 | 68.8 K to 66.2 K (-3.76 %) |
| May 04 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 62.41 | 341 | 21,281 | 68,781 | 68.4 K to 68.8 K (+0.50 %) |
| May 03 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 37.46 | 1,000 | 37,460 | 139,000 | |
| May 03 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 37.46 | 1,000 | 37,460 | 303,498 | 302.5 K to 303.5 K (+0.33 %) |